Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models. [electronic resource]
Producer: 20190821Description: 2040-2049 p. digitalISSN:- 2042-650X
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.